Mount Sinai Experts Show Neuroimaging Tests Can Reveal Disruptive Brain Changes Resulting from Vascular Disease Risk Factors Before the Appearance of Any Signs or Symptoms of Cardiovascular or Cerebrovascular Disease

NEW YORK (Oct. 22, 2014) –Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists from Icahn School of Medicine at Mount Sinai and published in the October issue of JACC Cardiovascular Imaging.

Boston Scientific Initiates Study of Promus Premier Coronary Stent System in Underserved Patient Populations

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease

Drug-Eluting Balloon Angioplasty Shows Excellent Results for Refractory Recurrent Carotid In-Stent Restenosis

October 16, 2014 — A long-term follow-up study reports on the safety and success of drug-eluting balloon angioplasty in treating patients with carotid in-stent restenosis that has proven refractory to treatment with balloon angioplasty and/or redo stenting. The results of this study are published in the current issue of the Journal of Endovascular Therapy. The researchers followed 9 patients with significant (more than 80 percent) recurrent restenosis who underwent drug-eluting balloon angioplasty.

Novel Lower Extremity Interventions

12th Biennial Meeting of the International Andreas Gruentzig Society:  Rio de Janeiro - February 2-6, 2014

Moderator:     Dieter Liermann
Panelists:      Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek

Framing the question at hand, what is the state of the current knowledge?

Mechanical Devices for Acute Stroke Intervention: Why Did the Trials Fail?

12th Biennial Meeting of the International Andreas Gruentzig Society:  Rio de Janeiro - February 2-6, 2014

From Session 7 — Endovascular

Moderator:     Dieter Liermann
Panelists:      Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek

Framing the question at hand, what is the state of the current knowledge?

NORD Establishes First Patient Organization for the One In A Million People Living with Lipoprotein Lipase Deficiency

The LPL Deficiency Association Is the First Organization Established as Part of NORDs RARELaunch Initiative

Danbury, Conn. – October 14, 2014 – The National Organization for Rare Disorders (NORD) has established the first patient organization dedicated to those living with the very rare genetic disease, lipoprotein lipase deficiency (LPLD), which affects approximately one in a million people. The LPL Deficiency Association™ was formed to provide support, education and awareness for people living with LPLD, their families, caregivers, and medical professionals.

The Lutonix 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

MURRAY HILL, N.J. — Oct. 10, 2014  C. R. Bard, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 Drug Coated Balloon (DCB) Catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length in native vascular disease of the superficial femoral or popliteal arteries with reference vessel diameters of 4-6mm. This approval follows a unanimous favorable recommendation from the FDA’s Circulatory Systems Devices Advisory Panel in June 2014.

Hybrid Imaging: Synergy and Co-registration of X-ray, CT and 3D Echo in the Interventional Suite

12th Biennial Meeting of the International Andreas Gruentzig Society:  Rio de Janeiro - February 2-6, 2014

From SESSION 6 — Structural

Moderator: Steve Bailey
Panelists: Kirk Garratt, Gyula Gal, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu

Framing the question at hand, what is the state of the current knowledge?

Penumbra Direct Aspiration System: Removing Clots for Acute Ischemic Stroke

12th Biennial Meeting of the International Andreas Gruentzig Society:  Rio de Janeiro - February 2-6, 2014

From SESSION 6 — Structural

Moderator:  Steve Bailey
Panelists: Kirk Garratt, Gyula Gal, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu

Framing the question at hand, what is the state of the current knowledge?


Back to top